 Sourav Poddar
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Athletic Injuries | 12 | 2024 | 526 | 1.690 |
Why?
| | Brain Concussion | 10 | 2024 | 573 | 1.410 |
Why?
| | Rotator Cuff Injuries | 6 | 2024 | 60 | 0.940 |
Why?
| | Athletes | 9 | 2024 | 422 | 0.860 |
Why?
| | Sports Medicine | 5 | 2024 | 112 | 0.800 |
Why?
| | Sports | 6 | 2023 | 231 | 0.590 |
Why?
| | Cartilage Diseases | 1 | 2017 | 39 | 0.520 |
Why?
| | Osteoarthritis | 3 | 2017 | 185 | 0.520 |
Why?
| | Return to Sport | 4 | 2024 | 97 | 0.500 |
Why?
| | Physical Therapy Modalities | 5 | 2024 | 308 | 0.420 |
Why?
| | Cartilage, Articular | 1 | 2017 | 309 | 0.410 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2022 | 58 | 0.350 |
Why?
| | Blood-Borne Pathogens | 2 | 2020 | 7 | 0.330 |
Why?
| | Physical Examination | 2 | 2021 | 240 | 0.310 |
Why?
| | Neuropsychological Tests | 5 | 2024 | 1022 | 0.290 |
Why?
| | Recovery of Function | 3 | 2024 | 652 | 0.260 |
Why?
| | Universities | 5 | 2024 | 433 | 0.240 |
Why?
| | Mesons | 3 | 2014 | 9 | 0.220 |
Why?
| | Post-Concussion Syndrome | 2 | 2024 | 174 | 0.210 |
Why?
| | Resistance Training | 2 | 2017 | 163 | 0.190 |
Why?
| | Rotator Cuff | 1 | 2022 | 47 | 0.180 |
Why?
| | Altitude | 3 | 2022 | 485 | 0.180 |
Why?
| | First Aid | 1 | 2021 | 11 | 0.180 |
Why?
| | Prospective Studies | 9 | 2024 | 7573 | 0.180 |
Why?
| | Consensus | 1 | 2024 | 678 | 0.170 |
Why?
| | Head Protective Devices | 1 | 2020 | 24 | 0.170 |
Why?
| | Medical History Taking | 1 | 2021 | 117 | 0.170 |
Why?
| | Emergency Medicine | 1 | 2023 | 226 | 0.170 |
Why?
| | Running | 1 | 2022 | 230 | 0.160 |
Why?
| | Humans | 34 | 2024 | 136803 | 0.160 |
Why?
| | Communicable Disease Control | 1 | 2020 | 82 | 0.160 |
Why?
| | Models, Theoretical | 2 | 2014 | 575 | 0.160 |
Why?
| | Football | 1 | 2020 | 85 | 0.160 |
Why?
| | Braces | 2 | 2017 | 19 | 0.150 |
Why?
| | Death, Sudden, Cardiac | 1 | 2020 | 185 | 0.150 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 180 | 0.150 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 62 | 0.150 |
Why?
| | Students | 2 | 2024 | 624 | 0.150 |
Why?
| | Acclimatization | 1 | 2019 | 177 | 0.140 |
Why?
| | Societies, Medical | 2 | 2019 | 817 | 0.140 |
Why?
| | Computer Simulation | 2 | 2020 | 973 | 0.140 |
Why?
| | Viscosupplements | 1 | 2017 | 11 | 0.140 |
Why?
| | Injections, Intra-Articular | 1 | 2017 | 49 | 0.140 |
Why?
| | Heart Diseases | 1 | 2020 | 346 | 0.130 |
Why?
| | Anesthetics, Local | 1 | 2017 | 80 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 350 | 0.120 |
Why?
| | Sex Factors | 1 | 2022 | 2064 | 0.120 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2017 | 124 | 0.120 |
Why?
| | Tendon Injuries | 2 | 2014 | 67 | 0.120 |
Why?
| | Mass Screening | 2 | 2020 | 1267 | 0.120 |
Why?
| | Electrons | 2 | 2014 | 83 | 0.110 |
Why?
| | Elementary Particles | 1 | 2014 | 12 | 0.110 |
Why?
| | Shoulder Pain | 1 | 2014 | 34 | 0.110 |
Why?
| | Quantum Theory | 1 | 2014 | 78 | 0.100 |
Why?
| | Biomarkers | 3 | 2022 | 4145 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2017 | 556 | 0.100 |
Why?
| | Male | 15 | 2024 | 67330 | 0.100 |
Why?
| | Shoulder Injuries | 1 | 2013 | 58 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 559 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2017 | 436 | 0.100 |
Why?
| | Nuclear Physics | 1 | 2012 | 13 | 0.100 |
Why?
| | Death, Sudden | 1 | 2012 | 24 | 0.100 |
Why?
| | Tendinopathy | 2 | 2014 | 27 | 0.100 |
Why?
| | Female | 15 | 2024 | 72816 | 0.100 |
Why?
| | Spectrum Analysis | 1 | 2012 | 91 | 0.090 |
Why?
| | Protons | 1 | 2012 | 89 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2024 | 5106 | 0.090 |
Why?
| | Glucose | 1 | 2017 | 1019 | 0.090 |
Why?
| | Hepcidins | 2 | 2022 | 22 | 0.090 |
Why?
| | Weight Loss | 1 | 2017 | 776 | 0.090 |
Why?
| | Physics | 1 | 2011 | 17 | 0.090 |
Why?
| | Gout | 1 | 2011 | 37 | 0.090 |
Why?
| | Ferritins | 2 | 2022 | 64 | 0.090 |
Why?
| | Physical Fitness | 1 | 2012 | 208 | 0.090 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 402 | 0.090 |
Why?
| | Uric Acid | 1 | 2011 | 163 | 0.080 |
Why?
| | Hemoglobins | 2 | 2022 | 353 | 0.080 |
Why?
| | Young Adult | 5 | 2024 | 13129 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2017 | 993 | 0.080 |
Why?
| | Prevalence | 3 | 2020 | 2710 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 2982 | 0.070 |
Why?
| | Achilles Tendon | 1 | 2008 | 32 | 0.070 |
Why?
| | Exercise | 3 | 2019 | 2044 | 0.070 |
Why?
| | Chondroitin | 1 | 2006 | 5 | 0.070 |
Why?
| | Glucosamine | 1 | 2006 | 13 | 0.070 |
Why?
| | Risk Factors | 5 | 2022 | 10332 | 0.060 |
Why?
| | Adolescent | 5 | 2024 | 21385 | 0.060 |
Why?
| | Trauma Severity Indices | 1 | 2005 | 106 | 0.060 |
Why?
| | Advisory Committees | 2 | 2020 | 219 | 0.060 |
Why?
| | Incidence | 2 | 2024 | 2797 | 0.060 |
Why?
| | Reflex Sympathetic Dystrophy | 1 | 2004 | 4 | 0.060 |
Why?
| | Evidence-Based Medicine | 2 | 2006 | 739 | 0.060 |
Why?
| | Cohort Studies | 2 | 2024 | 5704 | 0.050 |
Why?
| | Time Factors | 2 | 2024 | 6809 | 0.050 |
Why?
| | Awards and Prizes | 1 | 2024 | 67 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2024 | 10748 | 0.050 |
Why?
| | Aged | 6 | 2024 | 23808 | 0.050 |
Why?
| | Receptors, Transferrin | 1 | 2022 | 24 | 0.050 |
Why?
| | ROC Curve | 1 | 2024 | 545 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 164 | 0.050 |
Why?
| | Adult | 7 | 2024 | 37643 | 0.050 |
Why?
| | Middle Aged | 6 | 2024 | 33239 | 0.040 |
Why?
| | Practice Guidelines as Topic | 2 | 2023 | 1572 | 0.040 |
Why?
| | Hepatitis D | 1 | 2020 | 1 | 0.040 |
Why?
| | Acceleration | 1 | 2020 | 35 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 308 | 0.040 |
Why?
| | Iron | 1 | 2022 | 312 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2024 | 15510 | 0.040 |
Why?
| | Models, Anatomic | 1 | 2020 | 92 | 0.040 |
Why?
| | Hepatitis B | 1 | 2020 | 70 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2019 | 121 | 0.040 |
Why?
| | Creatine Kinase | 1 | 2019 | 79 | 0.040 |
Why?
| | Orthopedics | 1 | 2022 | 142 | 0.040 |
Why?
| | Head | 1 | 2020 | 105 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1936 | 0.040 |
Why?
| | Healthy Lifestyle | 1 | 2019 | 34 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 619 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | United States | 3 | 2020 | 14691 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2022 | 630 | 0.030 |
Why?
| | Hepatitis C | 1 | 2020 | 267 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 806 | 0.030 |
Why?
| | Health Education | 1 | 2020 | 338 | 0.030 |
Why?
| | Blood Glucose | 1 | 2006 | 2181 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2822 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3540 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1964 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 354 | 0.030 |
Why?
| | Knee Prosthesis | 1 | 1995 | 27 | 0.030 |
Why?
| | Oxygen | 1 | 2019 | 930 | 0.030 |
Why?
| | Animals | 1 | 2017 | 36850 | 0.030 |
Why?
| | Bone Transplantation | 1 | 1995 | 90 | 0.030 |
Why?
| | Rupture | 1 | 2014 | 92 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2019 | 761 | 0.030 |
Why?
| | Tibia | 1 | 1995 | 178 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2014 | 7593 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3556 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3265 | 0.030 |
Why?
| | Femur | 1 | 1995 | 254 | 0.020 |
Why?
| | Particle Accelerators | 1 | 2012 | 9 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2006 | 2518 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 521 | 0.020 |
Why?
| | Pain Measurement | 1 | 2014 | 521 | 0.020 |
Why?
| | Gout Suppressants | 1 | 2011 | 20 | 0.020 |
Why?
| | Allopurinol | 1 | 2011 | 63 | 0.020 |
Why?
| | Arthritis, Gouty | 1 | 2011 | 15 | 0.020 |
Why?
| | Hyperuricemia | 1 | 2011 | 44 | 0.020 |
Why?
| | Shoulder Joint | 1 | 2013 | 173 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2013 | 391 | 0.020 |
Why?
| | Safety | 1 | 2012 | 338 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4515 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3286 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1007 | 0.020 |
Why?
| | Nitroglycerin | 1 | 2008 | 17 | 0.020 |
Why?
| | Ultrasonics | 1 | 2008 | 49 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 149 | 0.020 |
Why?
| | Nonprescription Drugs | 1 | 2006 | 63 | 0.020 |
Why?
| | HIV Infections | 1 | 2020 | 2828 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 816 | 0.010 |
Why?
| | Sympathectomy | 1 | 2004 | 6 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2006 | 1062 | 0.010 |
Why?
| | Upper Extremity | 1 | 2004 | 99 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2014 | 5424 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1462 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5744 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2004 | 1481 | 0.010 |
Why?
| | Radiography | 1 | 1995 | 822 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1995 | 1167 | 0.000 |
Why?
| | Postoperative Complications | 1 | 1995 | 2639 | 0.000 |
Why?
|
|
Poddar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|